PipelinePharma Logo

Generics 15

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Brivaracetam manufacturers

15 products found

Filters

15 products found

brivaracetam

Tablets 10 mg, 25 mg, 50 mg, 75 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Available for
Distribution only
Comments
Ref. Briviact
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

brivaracetam

Tablets, film coated 10 mg, 25 mg, 50 mg, 75 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Briviact®
Manufacturer #252

Manufacturer usually replies in 2 days

brivaracetam

Tablets, film coated 10 mg, 25 mg, 50 mg, 75 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
DCP Jan 24
Manufacturer #21467

Manufacturer usually replies in 9 days

brivaracetam

Solution for infusion 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Latvia , Lithuania
Manufacturer #2346

Manufacturer usually replies in 7 days

brivaracetam

Oral solution 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Latvia , Lithuania
Manufacturer #2346

Manufacturer usually replies in 7 days

brivaracetam

Oral solution 10 mg/ml - 300 ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Comments
CTD with BE with Briviact for Q1 2025
Manufacturer #10620
A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, the Middle East, North America, LATAM, and Asia for 50+ years. The main therapeutic areas include cardiovascular, rheumatology, nephrology, and central nervous system. The main dosage forms are oral solid and multi-dose powder. They are produced in GMP-compliant manufacture.

Manufacturer usually replies in 14 days

brivaracetam

Tablets, film coated 10 mg, 25 mg, 50 mg, 75 mg , 100 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Chile , Panama
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

brivaracetam

Tablets 2.5 mg, 10 mg, 15 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Manufacturer #12677

Manufacturer usually replies in 4 days

brivaracetam

Tablets 10 mg, 25 mg, 50 mg, 75 mg, 100 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #13095

Manufacturer usually replies in 5 days

brivaracetam

Tablets 10 mg, 25 mg, 50 mg, 75 mg, 100 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 5 days

brivaracetam

Vials, injection 50 mg, 100 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 7 days

brivaracetam

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 7 days

brivaracetam

Tablets 10 mg, 25 mg, 50 mg, 75 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP, WHO
Manufacturer #18908

Manufacturer usually replies in 11 days

brivaracetam

Oral solution 10 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #28571

Manufacturer usually replies in nan days

brivaracetam

Tablets 100 mg, 25 mg, 50 mg, 75 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #31070

Manufacturer usually replies in nan days

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers